Dragani, M., Chiusolo, P., Rivoli, G., Cerrano, M., Aprile, L., Borlenghi, E., Cambò, B., Bellis, E. D., Defina, M., Fucci, L., Giubbolini, R., Gurrieri, C., Papayannidis, C., Roncoroni, E., Urbano, M. A., Foà, R., Chiaretti, S. (2025). Asciminib for relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) and lymphoid blast crisis of chronic myeloid leukemia (LBC-CML) in Italy: A Campus ALL real life study. Blood. https://doi.org/10.1182/blood-2025-1572